Development of a fluorescence aptasensor based on DNA nanotrain structure for the detection of ampicillin
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy · 2026
DOI: 10.1016/j.saa.2025.127239 ↗Kurz gefasst
Fachartikel in der Zeitschrift Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2026. Verfasst von Emad Azimi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Targeted Drug Delivery Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Pha…. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, Ampicillin, Biosensing Techniques, DNA. Die Arbeit nennt 49 Literaturangaben. Gefördert von: Mashhad University of Medical Sciences.
Abstract (Originalsprache)
Ampicillin, a betalactam antibiotic, is used to treat hospital disorders such as gastrointestinal, urogenital, and skin infections. Seizures and hypersensitivity responses are possible adverse effects of this medication. This study aims to qualitatively and quantitatively determine the presence of ampicillin through the use of the fluorescence technique. In this strategy, a DNA nanotrain configuration was developed that consists of a sequence of complementary strands connected to an ampicillin aptamer, which was affixed to a mesoporous silica nanoparticle. The resultant double-stranded segments created an ideal loading zone for the fluorescent compound picogreen, leading to a significant fluorescence emission. Under ideal conditions, the created fluorescent sensing approach demonstrated excellent selectivity for ampicillin, achieving a limit of detection (LOD) of 0.2 nM. The developed aptasensor demonstrated two separate linear intervals, ranging from 0.5 to 10 nM and from 60 to 200 nM. In summary, the suggested approach has the potential to provide a solid basis for the analysis of small molecules, thereby guaranteeing the safety of food and humans by utilizing suitable aptamer sequences.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Targeted Drug Delivery Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of M…
- Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
- Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Medicinal Chemistry, School of Pharmacy, Mashhad University of Medical Sciences,…
Förderung
- Mashhad University of Medical Sciences
Zitieren
APA
Azimi, E., Sameiyan, E., Ghaffari, R., Shafaghi, A., Ramezani, M., Alibolandi, M., Abnous, K., & Taghdisi, S. M. (2026). Development of a fluorescence aptasensor based on DNA nanotrain structure for the detection of ampicillin. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. https://doi.org/10.1016/j.saa.2025.127239
Vancouver
Azimi E, Sameiyan E, Ghaffari R, Shafaghi A, Ramezani M, Alibolandi M, et al. Development of a fluorescence aptasensor based on DNA nanotrain structure for the detection of ampicillin. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2026. doi:10.1016/j.saa.2025.127239
BibTeX
@article{Azimi2026,
author = {Azimi, Emad and Sameiyan, Elham and Ghaffari, Reza and Shafaghi, Abouzar and Ramezani, Mohammad and Alibolandi, Mona and Abnous, Khalil and Taghdisi, Seyed Mohammad},
title = {Development of a fluorescence aptasensor based on DNA nanotrain structure for the detection of ampicillin},
journal = {Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy},
year = {2026},
doi = {10.1016/j.saa.2025.127239}
}
EUVIMED